Review: Cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy
暂无分享,去创建一个
R O Weller | R N Kalaria | R. Carare | R. Kalaria | R. Weller | C. Hawkes | M. Jeffrey | R O Carare | C A Hawkes | M Jeffrey | R. O. Carare | R. Kalaria | Martin Jeffrey | Roy O. Weller | R. N. Kalaria | Cheryl A. Hawkes
[1] B. Chesebro,et al. Non‐amyloid and amyloid prion protein deposits in prion‐infected mice differ in blockage of interstitial brain fluid , 2013, Neuropathology and applied neurobiology.
[2] G. E. Vates,et al. A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β , 2012, Science Translational Medicine.
[3] R. Carare,et al. Disruption of Arterial Perivascular Drainage of Amyloid-β from the Brains of Mice Expressing the Human APOE ε4 Allele , 2012, PloS one.
[4] I. Bechmann,et al. Migration of monocytes after intracerebral injection at entorhinal cortex lesion site , 2012, Journal of leukocyte biology.
[5] S. Wiese,et al. Astrocytes as a Source for Extracellular Matrix Molecules and Cytokines , 2012, Front. Pharmacol..
[6] Irina S. Alexeeva,et al. A New Mechanism for Transmissible Prion Diseases , 2012, The Journal of Neuroscience.
[7] V. Perry,et al. Intracerebral immune complex formation induces inflammation in the brain that depends on Fc receptor interaction , 2012, Acta Neuropathologica.
[8] S. Love,et al. Intrastriatal convection-enhanced delivery results in widespread perivascular distribution in a pre-clinical model , 2012, Fluids and Barriers of the CNS.
[9] Irina S. Alexeeva,et al. Genesis of Mammalian Prions: From Non-infectious Amyloid Fibrils to a Transmissible Prion Disease , 2011, PLoS pathogens.
[10] S. Love,et al. Elimination of Amyloid β from the Brain, its Failure in Alzheimer's Disease and Implications for Therapy , 2011 .
[11] Marek Belohlavek,et al. Transcranial Doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer’s disease , 2011, Alzheimer's & Dementia.
[12] S. Gygi,et al. Hypomorphic Notch 3 alleles link Notch signaling to ischemic cerebral small-vessel disease , 2011, Proceedings of the National Academy of Sciences.
[13] W. Olbricht,et al. Fluid mechanics in the perivascular space. , 2011, Journal of theoretical biology.
[14] G. Schellenberg,et al. Familial prion disease with alzheimer disease‐like tau pathology and clinical phenotype , 2011, Annals of neurology.
[15] M. Baumann,et al. Review: Molecular genetics and pathology of hereditary small vessel diseases of the brain , 2011, Neuropathology and applied neurobiology.
[16] Reinhard Schliebs,et al. Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy , 2011, Acta Neuropathologica.
[17] R. Carare,et al. Pathophysiology of the lymphatic drainage of the central nervous system: Implications for pathogenesis and therapy of multiple sclerosis. , 2010, Pathophysiology : the official journal of the International Society for Pathophysiology.
[18] J. Gastier-Foster,et al. Novel diagnostic features of dysferlinopathies , 2010, Muscle & nerve.
[19] B. Schmidt-Sidor,et al. Original article Capillary vessel wall in CADASIL angiopathy , 2010 .
[20] J. Attems,et al. Capillary cerebral amyloid angiopathy identifies a distinct APOE ε4-associated subtype of sporadic Alzheimer’s disease , 2010, Acta Neuropathologica.
[21] W. Halfter,et al. Age-dependent changes in the structure, composition and biophysical properties of a human basement membrane. , 2010, Matrix biology : journal of the International Society for Matrix Biology.
[22] M. Moskowitz,et al. Migraine aura pathophysiology: the role of blood vessels and microembolisation , 2010, The Lancet Neurology.
[23] B. Chesebro,et al. Fatal Transmissible Amyloid Encephalopathy: A New Type of Prion Disease Associated with Lack of Prion Protein Membrane Anchoring , 2010, PLoS pathogens.
[24] A. Schedl,et al. Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. , 2010, The Journal of clinical investigation.
[25] Irina S. Alexeeva,et al. Recombinant prion protein induces a new transmissible prion disease in wild-type animals , 2010, Acta Neuropathologica.
[26] G. Dienel,et al. Trafficking of Glucose, Lactate, and Amyloid-β from the Inferior Colliculus through Perivascular Routes , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[27] F. Baas,et al. Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP , 2009, Acta Neuropathologica.
[28] M. Dichgans,et al. CADASIL , 2009, The Lancet Neurology.
[29] B. Chesebro,et al. Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. , 2009, Annual review of biochemistry.
[30] S. Sisó,et al. Neuroinvasion in sheep transmissible spongiform encephalopathies: the role of the haematogenous route , 2009, Neuropathology and applied neurobiology.
[31] Berislav V. Zlokovic,et al. Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.
[32] R. Weller,et al. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy , 2009, Acta Neuropathologica.
[33] G. Plant,et al. Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies , 2009, Acta Neuropathologica.
[34] M. Viitanen,et al. Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients , 2009, Brain : a journal of neurology.
[35] J. McLaurin,et al. Selective targeting of perivascular macrophages for clearance of β-amyloid in cerebral amyloid angiopathy , 2009, Proceedings of the National Academy of Sciences.
[36] R O Weller,et al. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. , 2008, Brain : a journal of neurology.
[37] R. Carare,et al. Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. , 2008, Brain pathology.
[38] S. Love,et al. Abeta-degrading enzymes in Alzheimer's disease. , 2008, Brain pathology.
[39] R O Weller,et al. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology , 2008, Neuropathology and applied neurobiology.
[40] R. Carare,et al. SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Perivascular Drainage of Amyloid‐β Peptides from the Brain and Its Failure in Cerebral Amyloid Angiopathy and Alzheimer's Disease , 2007 .
[41] A. Cedazo-Mínguez,et al. Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities , 2007, Journal of cellular and molecular medicine.
[42] M. Jeffrey,et al. Classical sheep transmissible spongiform encephalopathies: pathogenesis, pathological phenotypes and clinical disease , 2007, Neuropathology and applied neurobiology.
[43] H. Chabriat,et al. Cortical Neuronal Apoptosis in CADASIL , 2006, Stroke.
[44] E. Nagata,et al. Notch3 ectodomain is a major component of granular osmiophilic material (GOM) in CADASIL , 2006, Acta Neuropathologica.
[45] T. Tabira,et al. CADASIL-causing mutations do not alter Notch3 receptor processing and activation , 2006, Neuroreport.
[46] V. Perry,et al. Mechanisms to explain the reverse perivascular transport of solutes out of the brain. , 2006, Journal of theoretical biology.
[47] Mathias Jucker,et al. Mechanism of Cerebral β‐Amyloid Angiopathy: Murine and Cellular Models , 2006 .
[48] M. Frosch,et al. The Cerebral β‐Amyloid Angiopathies: Hereditary and Sporadic , 2006 .
[49] E. Masliah,et al. Anchorless Prion Protein Results in Infectious Amyloid Disease Without Clinical Scrapie , 2005, Science.
[50] D. Holtzman,et al. Human Apolipoprotein E4 Alters the Amyloid-β 40:42 Ratio and Promotes the Formation of Cerebral Amyloid Angiopathy in an Amyloid Precursor Protein Transgenic Model , 2005, The Journal of Neuroscience.
[51] B. Lévy,et al. Impaired Vascular Mechanotransduction in a Transgenic Mouse Model of CADASIL Arteriopathy , 2005, Stroke.
[52] D. Dickson,et al. Extracellular Deposits of Aβ Produced in Cultures of Alzheimer Disease Brain Vascular Smooth Muscle Cells , 2005 .
[53] M. Johnston,et al. Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species , 2004, Cerebrospinal Fluid Research.
[54] M. Viitanen,et al. Fibrosis and Stenosis of the Long Penetrating Cerebral Arteries: the Cause of the White Matter Pathology in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy , 2004, Brain pathology.
[55] A. Danek,et al. Aging is associated with increased collagen type IV accumulation in the basal lamina of human cerebral microvessels , 2004, BMC Neuroscience.
[56] T. Saido,et al. Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Aβ to physiologically relevant proteolytic degradation , 2003, The Lancet.
[57] M. Jeffrey,et al. Distinct profiles of PrP(d) immunoreactivity in the brain of scrapie- and BSE-infected sheep: implications for differential cell targeting and PrP processing. , 2003, The Journal of general virology.
[58] C. Godfraind,et al. Morphometric analysis of ultrastructural vascular changes in CADASIL: analysis of 50 skin biopsy specimens and pathogenic implications , 2002, Acta Neuropathologica.
[59] A. Roher,et al. Exogenous induction of cerebral β-amyloidosis in βAPP-transgenic mice , 2002, Peptides.
[60] Y. Kiuchi,et al. Type IV collagen prevents amyloid β-protein fibril formation , 2002 .
[61] Pawel P. Liberski,et al. Deposition patterns of disease-associated prion protein in captive mule deer brains with chronic wasting disease , 2001, Acta Neuropathologica.
[62] D. Holtzman,et al. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. , 2000, The Journal of clinical investigation.
[63] D. Kirschner,et al. Laminin inhibition of β‐amyloid protein (Aβ) fibrillogenesis and identification of an Aβ binding site localized to the globular domain repeats on the laminin a chain , 2000 .
[64] M. Rafii,et al. Agrin and microvascular damage in Alzheimer's disease , 2000, Neurobiology of Aging.
[65] T. Beach,et al. Cholinergic deafferentation of the rabbit cortex: a new animal model of Aβ deposition , 2000, Neuroscience Letters.
[66] D. Clair,et al. Detection of complement factor B in the cerebrospinal fluid of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy disease using two-dimensional gel electrophoresis and mass spectrometry , 2000, Neuroscience Letters.
[67] F. Chapon,et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. , 2000, The Journal of clinical investigation.
[68] M. Jeffrey,et al. Determination of the frequency and distribution of vascular and parenchymal amyloid with polyclonal and N-terminalspecific PrP antibodies in scrapie-affected sheep and mice , 1998, Veterinary Record.
[69] T. Wight,et al. Perlecan Binds to the β‐Amyloid Proteins (Aβ) of Alzheimer's Disease, Accelerates Aβ Fibril Formation, and Maintains Aβ Fibril Stability , 1997 .
[70] J. Haines,et al. ApoE-4 and Age at Onset of Alzheimer's Disease , 1997, Neurology.
[71] N. Inestrosa,et al. Laminin inhibits amyloid-β-peptide fibrillation , 1996, Neuroscience Letters.
[72] B. Ghetti,et al. Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[73] P. Fraser,et al. An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar aβ-amyloid in rat brain , 1994, Neuron.
[74] R O Weller,et al. CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance , 1993, Neuropathology and applied neurobiology.
[75] J. Pickard. Physiology and Pathophysiology of the Cerebrospinal Fluid , 1988 .
[76] O. R. Blaumanis,et al. Evidence for a ‘Paravascular’ fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space , 1985, Brain Research.
[77] C. Patlak,et al. Drainage of interstitial fluid from different regions of rat brain. , 1984, The American journal of physiology.
[78] S. Sisó,et al. Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease , 2010, Acta Neuropathologica.
[79] R. Kalaria,et al. Mutations in NOTCH3 cause the formation and retention of aggregates in the endoplasmic reticulum, leading to impaired cell proliferation. , 2010, Human molecular genetics.
[80] B. Schmidt-Sidor,et al. Capillary vessel wall in CADASIL angiopathy. , 2010, Folia neuropathologica.
[81] R. Carare,et al. Lymphatic drainage of the brain and the pathophysiology of neurological disease , 2008, Acta Neuropathologica.
[82] A. Palsdottir,et al. Hereditary cystatin C amyloid angiopathy: genetic, clinical, and pathological aspects. , 2006, Brain pathology.
[83] Mathias Jucker,et al. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. , 2006, Brain pathology.
[84] M. Frosch,et al. The cerebral beta-amyloid angiopathies: hereditary and sporadic. , 2006, Brain pathology.
[85] D. Dickson,et al. Extracellular deposits of A beta produced in cultures of Alzheimer disease brain vascular smooth muscle cells. , 2005, Journal of neuropathology and experimental neurology.
[86] E. Zhang,et al. Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain , 2004, Acta Neuropathologica.
[87] A. Roher,et al. Exogenous induction of cerebral beta-amyloidosis in betaAPP-transgenic mice. , 2002, Peptides.
[88] Y. Kiuchi,et al. Type IV collagen prevents amyloid beta-protein fibril formation. , 2002, Life sciences.
[89] L. Mucke,et al. Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. , 2000, The American journal of pathology.
[90] D. Kirschner,et al. Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain. , 2000, Journal of neuroscience research.
[91] T. Wight,et al. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability. , 1997, Journal of neurochemistry.
[92] D. Premkumar,et al. Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease. , 1996, Brain research. Molecular brain research.
[93] N. Inestrosa,et al. Laminin inhibits amyloid-beta-peptide fibrillation. , 1996, Neuroscience letters.
[94] J. Wegiel,et al. Beta-amyloid formation by myocytes of leptomeningeal vessels. , 1994, Acta neuropathologica.
[95] C. Sigurdson,et al. [Prion diseases?]. , 1985, Deutsche medizinische Wochenschrift.